Access Engagement & HTA Head

Job Description

Key Responsibilities

• Shape policy and HTA dialogue with MoH, CNHI/CHTA and CHI , anticipating evolving evidence, economic and value requirements and translating them into portfolio, brand and evidence plans.
• Lead the KSA portfolio HTA and Economic Evaluation Study strategy , including Saudi-adapted economic models, local epidemiology, real-world evidence and appropriate comparators, in close partnership with HEMAR and Medical Affairs.
• Monitor major healthcare-system developments, including Vision 2030 healthcare transformation, financing reform and privatization , and translate them into clear access implications, risks and opportunities for the leadership team.
• Activate relevant priorities across HTA and EES activities, strengthening strategic contracting, price protection, value and pricing policy, portfolio value narratives and stakeholder prioritization.
• Represent J&J Innovative Medicine credibly in appropriate policy forums, industry associations and public-private initiatives .
• Establish and deepen strategic relationships with emerging healthcare stakeholders, including CNHI, HHC and healthcare clusters, provider economic functions, and purchasing/contracting organizations .
• Serve as a key Market Access interface with transforming the healthcare ecosystem, identifying changes early and translating them into actionable access opportunities.
• Support developing the innovative access solutions including value-based agreements, outcomes-based contracting, innovative financing, early-access and managed-entry approaches , aligned with evolving purchasing and reimbursement models.
• Develop high-level health-transformation plans reflecting HHC and cluster priorities and connect these plans with portfolio priorities and launch sequencing.
• Apply an integrated planning discipline to strategic access initiatives, with quantified ambition, clear DRI ownership, defined milestones and regular continue/refine/scale/stop decisions .
• Partner with Medical, Commercial, Regulatory, HEMAR and other Access team members to align portfolio strategies with emerging pathways and strengthen organizational readiness for the new healthcare model.
• Build a differentiated customer-facing access engagement model , segmenting stakeholders according to influence, strategic importance and access impact.
• Expand Market Access engagement beyond traditional purchasing stakeholders to include cluster leadership, finance, contracting, HTA committees, insurers and other emerging access decisionmakers .
• Establish a disciplined after-action review approach to evaluate stakeholder reach, conversion, follow-through and value-message effectiveness , translating insights into future engagement priorities.
• Connect national access achievements with account-level execution, ensuring formulary and tender wins translate into sustainable patient access and uptake .

Key Accountabilities / Measures of Success

HTA & Environment Shaping

Health Transformation

Access Engagement

Qualifications & Experience

• Bachelor’s degree in pharmacy, life sciences, medicine, health economics or a related field; an advanced degree (MSc, MBA, MPH, PharmD or health economics) is preferred.
• 6-10+ years in pharmaceutical or healthcare roles with a strong track record in market access, HEMAR, health policy or health-system transformation; KSA experience is essential.
• Deep working knowledge of the Saudi health system and Vision 2030 - CNHI, HHC and clusters, MoH, SFDA, CHI — and of HTA / EES, formulary and NUPCO tender pathways.
• Demonstrated ability to build senior external relationships and deliver access outcomes across specialty therapy areas.
• Fluency in Arabic and English